Sugammadex, a revolutionary drug for reversing neuromuscular blockade during anesthesia, has become a mainstay in operating rooms worldwide. But its journey from scientific concept to patient benefit starts far from the sterile environment of the hospital – it begins in the intricate world of Active Pharmaceutical Ingredient (API) manufacture. Sugammadex Sodium API, the key component of the...